🇺🇸

US SEC Filing Intelligence

· daily

S&P 500 Industrials Sector SEC Filings — May 21, 2026

The 50 filings from S&P 500 Industrials reveal a sector bifurcated between resilient capital-goods players and deeply distressed small-caps. Deere & Co. posted a 5% revenue increase but saw its Production & Precision Agriculture segment profit plunge 39%, while Advanced Drainage Systems reported 9.9% top-line growth but a 54% GAAP net income collapse due to acquisition costs. The most transformative event is the $69B AvalonBay/Equity Residential merger of equals, creating a multifamily REIT behemoth with $125M in net synergies. Capital allocation is defensive: Tractor Supply secured a new credit facility, Barnwell raised $3.4M via equity issuance, and Unity Bancorp maintained a $0.16 dividend. A wave of 14 Puerto Rico closed-end funds announced strategic reviews to convert to open-end structures, signaling a structural shift in that market. Insider activity is sparse but notable, with Nocopi Technologies insiders participating in a private placement alongside a transformative acquisition. The overarching theme is 'scale or die'—companies are using M&A and restructuring to navigate margin pressure while cash-strapped micro-caps like Dalrada face acute liquidity risk.

26 high priority 24 medium 50 total filings
· daily

S&P 500 Energy Sector SEC Filings — May 21, 2026

The S&P 500 Energy sector filings today reveal a bifurcated landscape: aggressive capital deployment into upstream acreage and midstream consolidation, contrasted with mixed operational performance and margin pressure. Devon Energy's $2.6B Delaware Basin acquisition at $161,500/acre signals strong conviction in Permian economics, while Baker Hughes' EC filing for the Chart Industries merger (expected July 2026) advances a transformative midstream deal. However, Copart's Q3 FY2026 results show domestic revenue stagnation (U.S. service revenues -2.1% YoY for nine months) offset by international strength (+11.4% YoY), and ONEOK's annual meeting confirmed stable governance. EOG Resources' doubling of its buyback authorization to $20B (with $2.9B remaining) underscores sector-wide capital return momentum, though Nocopi's dilutive $2.65M acquisition (500K shares issued) highlights small-cap execution risk. Insider activity is muted across filings, but the absence of selling in large caps is notable. Portfolio-level trends show capital discipline (buybacks > dividends) and a pivot toward high-return basin acreage, while margin compression in services (Copart U.S. operating income -0.5% YoY) warrants monitoring.

2 high priority 7 medium 9 total filings
· daily

US Material Events SEC 8-K Filings — May 21, 2026

The May 21, 2026, material events stream is dominated by transformative M&A and capital allocation activity, signaling a period of aggressive portfolio reshaping and strategic pivots across sectors. The $69 billion AvalonBay/Equity Residential merger of equals is the headline event, creating a multifamily REIT behemoth with $175 million in targeted synergies, though leadership transition risks and shareholder approval hurdles remain. Concurrently, we see a wave of capital market activity: Onto Innovation's $1.3B zero-coupon convertible offering (with a 50% conversion premium) and Trinity Capital's $300M note issuance highlight a bifurcated market where high-growth and credit-oriented firms are aggressively locking in low-cost, long-duration capital. A notable pattern of strategic divestitures and pivots is emerging, with Sun Communities selling its UK assets for $1.03B to refocus on North America, Skillsoft divesting Global Knowledge to sharpen its AI focus, and Hoth Therapeutics restructuring entirely into an AI semiconductor company. Insider and governance signals are mixed; while several companies are strengthening boards with high-profile talent (Constellation Brands, Veritone), others face significant shareholder dissent on compensation and equity plans (BankUnited, Rithm Capital), and a wave of CFO retirements and transitions (Erie Indemnity, Omega Healthcare, Skillsoft) introduces execution risk. The data reveals a market that is rewarding strategic clarity and financial engineering, while punishing governance lapses and unclear strategies.

50 high priority 50 total filings
· daily

Dow Jones 30 Stocks SEC Filings — May 21, 2026

The 50 filings for Dow 30 constituents on May 21, 2026, are dominated by a single mega-deal: the $52B all-stock merger of equals between AvalonBay Communities and Equity Residential, creating the largest multifamily REIT in history with over 180,000 units. This transaction, covered across six separate filings, signals a defensive consolidation play in a maturing sector where geographic performance has diverged sharply. Beyond AvalonBay, the batch reveals a defensive tilt in capital allocation: S&P Global advances its Mobility spin-off (record date June 15, distribution July 1), Baker Hughes pushes its Chart Industries acquisition through EC review for a July close, and Advance Auto Parts reports its strongest comparable sales in five years (up 3.5%) alongside massive margin recovery (adjusted operating income up 410 bps YoY). However, red flags are flashing for smaller-cap names: Apple iSports Group has just $860 cash remaining with zero revenue, SpringBig Holdings lost board control to noteholders, and Hemab Therapeutics' cash burn is accelerating. Period-over-period data shows wide divergence—Walmart's e-commerce surged 26% globally while Barnwell Industries' revenue fell 29%, illustrating the bifurcation between scale-driven leaders and energy-exposed laggards.

25 high priority 25 medium 50 total filings
· daily

US SEC Filings Daily Market Digest — May 21, 2026

Today's digest is dominated by two transformative mega-mergers in the real estate sector: AvalonBay Communities and Equity Residential's $69 billion all-stock merger of equals, and Sun Communities' $1.03 billion sale of its UK assets to refocus on North America. These deals signal a wave of consolidation and strategic refocusing in the REIT space. On the earnings front, Deere & Co. reported a mixed quarter with a 2% net income decline but maintained full-year guidance, while e.l.f. Beauty saw a sharp 76.5% net income drop despite 24.6% revenue growth due to acquisition-related charges. The biotech sector showed a stark contrast, with Immix Biopharma reporting a compelling 95% CR rate in a Phase 2 trial, while Brainstorm Cell Therapeutics filed for a dilutive offering with flat losses. A notable pattern is the surge in Puerto Rico closed-end funds (14 filings) announcing strategic reviews to convert to open-end structures, a significant liquidity event for a niche market. Overall, the day is characterized by high-conviction corporate actions, mixed earnings quality, and a cautious capital-raising environment for smaller companies.

27 high priority 23 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — May 21, 2026

The 50 filings for the S&P 500 Consumer Discretionary sector reveal a bifurcated landscape where discount retailers and value-oriented concepts are thriving, while other segments face margin pressure and liquidity concerns. Walmart and Ross Stores delivered standout quarters with strong revenue growth of 7.3% and 21% YoY respectively, driven by market share gains and value-seeking consumers, though Walmart's free cash flow turned sharply negative. e.l.f. Beauty reported robust 24.6% net sales growth but saw net income collapse 76.5% due to acquisition-related charges, highlighting the cost of aggressive M&A. The homebuilding sector saw a major unsolicited bid from Dream Finders Homes for Beazer Homes, signaling potential consolidation. Auto and restaurant filings were sparse, but Ford's DOE loan agreement for battery facilities indicates continued EV investment. A significant cluster of 14 Puerto Rico closed-end funds announced strategic reviews to convert to open-end structures, a major liquidity event for that market. Insider trading activity was minimal across filings, but several annual meetings revealed notable shareholder dissent on executive compensation, particularly at First Watch and Braemar Hotels.

25 high priority 25 medium 50 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — May 21, 2026

The 32 filings in this S&P 500 Healthcare stream reveal a sector in transition, with strong operational performance at firms like Cirrus Logic (revenue +5.3% YoY, net income +25%) contrasting with acute distress at Dalrada Technology (revenue -44% YoY, negative equity). Capital allocation is active: News Corp authorized a $1B buyback, Broadridge raised its dividend, and Medallion Financial highlighted record earnings amid a proxy fight. M&A activity is notable with Columbia Financial/Northfield Bancorp merger and Greenland Mines' $35M acquisition. Insider trading is sparse, but the proxy contest at Medallion and withheld votes at Kingsway and HBT Financial signal governance concerns. Forward-looking catalysts include Jupiter Neurosciences' $2M offering for Parkinson's trial and NanoViricides' Ebola commentary. Overall, the sector shows bifurcation between profitable incumbents and cash-burning biotechs, with regulatory and shareholder activism risks.

8 high priority 24 medium 32 total filings
· daily

US Executive Compensation Proxy SEC Filings — May 21, 2026

This batch of 8 proxy filings reveals a bifurcated landscape: 25% of filers are in severe financial distress, resorting to reverse stock splits and SPAC deadline extensions to preserve listing and survival, while the remaining companies present stable governance with routine proposals. A critical theme is the high rate of leadership instability, most notably at Cue Biopharma which has cycled through three CEOs in under eight months amidst a transformative licensing deal, signaling deep operational turmoil. Capital allocation actions are defensive rather than growth-oriented, with Allied Gaming, Edible Garden, and Centurion Acquisition all seeking shareholder approval for capital structure changes that dilute or restructure equity. Insider activity across the set is minimal and not signaling conviction—most insider holdings are under 1%, and no material insider buying or selling was detected in any filing. Forward-looking data is sparse, limited to corporate action deadlines rather than operational guidance, creating a vacuum of performance visibility that heightens risk for smaller-cap filers. The SPAC sector remains under acute time pressure, with Centurion's $312 million trust at risk of full liquidation if its extension fails, representing the largest binary event in this cohort.

8 high priority 8 total filings
· daily

US IPO Pipeline SEC S-1 Filings — May 21, 2026

The IPO pipeline on May 21, 2026, reveals a bifurcated market: two distressed biotech resale registrations (Brainstorm Cell Therapeutics and Azitra) signal severe capital needs and shareholder dilution, while one blank-check company (BTECH Corp) launches a $200 million SPAC targeting the oil and gas and energy transition sectors. Period-over-period data shows Brainstorm's net losses flat at $22.589 million for two consecutive years, indicating no operational progress, while Azitra's assets of only $5.0 million and a going concern opinion underscore acute financial fragility. In contrast, BTECH's SPAC structure offers a clean slate with no operating history, but immediate dilution from sponsor shares at $0.003 per share is a structural risk. The absence of insider trading activity across all three filings suggests management is not signaling conviction through personal investment. The overarching theme is capital desperation in biotech versus speculative SPAC capital formation in energy, with all three filings carrying high dilution risk for investors.

3 high priority 3 total filings
· daily

Global High-Priority Regulatory Events — May 21, 2026

Today's filing stream (May 21, 2026) reveals a market dominated by three major themes: a landmark consolidation in US REITs with the $69B AvalonBay-Equity Residential merger, a systemic liquidity crisis at Dalrada Technology Group, and a coordinated structural shift by 14 Puerto Rico closed-end funds toward open-end structures. Period-over-period data shows decelerating growth in Indian conglomerates (ITC's revenue +10% YoY but profit only +1%) and extreme revenue contraction in micro-cap energy (Barnwell -29% YoY) and technology (Dalrada -44% YoY). Capital allocation is mixed—aggressive buybacks from Dhanuka Agritech (₹70Cr) and Zydus Lifesciences (₹1,100Cr) contrast with severe cash burn at Dalrada (cash down 52% to $82.6K). A notable pattern of leadership churn emerged with Glimpse Group losing its entire C-suite and Radian Group announcing a CEO transition, while insider activity remains sparse across the stream. The most actionable signals arise from the AvalonBay-EQR merger synergies ($175M gross), Obsidian Therapeutics' promising Phase 2 melanoma data (67% ORR), and the pivot-to-liquidity event across 14 Puerto Rico funds, which may unlock trapped NAV for investors.

50 high priority 50 total filings
· daily

US Earnings Financial Results SEC Filings — May 21, 2026

The 22 filings reveal a bifurcated market: consumer-facing and tech companies (e.g., e.l.f. Beauty, Logitech, Ralph Lauren) show robust top-line growth, but margin pressures from rising costs and acquisition-related charges are compressing net income. Conversely, the semiconductor and industrial sectors (Applied Materials, Allegro MicroSystems, Nordson) demonstrate strong cyclical recoveries with double-digit revenue and earnings growth. A critical undercurrent is acute liquidity stress at micro-cap companies (Dalrada, Apple iSports, Barnwell), where cash burn and negative equity signal potential distress. Capital allocation is a key differentiator: strong operators like Cirrus Logic and Hamilton Lane are returning capital via buybacks, while others (Advanced Drainage Systems, Thermon) are absorbing restructuring costs. Insider trading data is sparse, but the lack of insider buying at struggling firms is a notable negative signal. The overarching theme is that quality and scale are rewarded, while smaller, cash-poor entities face existential risks.

22 high priority 22 total filings
· daily

US SEC Trading Suspension Halt Orders — May 21, 2026

The two filings in this stream both involve US exchange listing compliance issues, highlighting a theme of regulatory and financial distress among smaller-cap companies. Picard Medical shows a stark contrast between strong operational improvement (85% YoY revenue growth, achieving a positive gross margin of 24%) and a deteriorating balance sheet (stockholders' deficit of $(1.4)M), leading to two NYSE American delisting notices. Hub Group's situation is a non-operational, administrative delay in filing its Q1 2026 10-Q, following a prior delay on its 2025 10-K, which has resulted in a Nasdaq non-compliance notice. The key portfolio-level trend is the divergence between operational performance and financial/regulatory health, with Picard's growth being overshadowed by solvency risks, while Hub Group's risk is purely procedural. The most critical development is Picard's June 7, 2026 deadline to submit a compliance plan, which will be a key catalyst for its stock. No insider trading activity was reported in either filing, removing a key sentiment gauge.

2 high priority 2 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — May 21, 2026

The 50 filings reveal a bifurcated market with aggressive capital raising and strategic portfolio reshaping amid rising distress signals. A dominant theme is the wave of equity and debt offerings, with 12 companies raising capital through dilutive stock sales, convertible notes, or private placements, signaling acute cash needs. Concurrently, major portfolio optimization is underway, highlighted by the $69 billion AvalonBay/Equity Residential merger of equals and significant divestitures by Kontoor Brands (Lee® for up to $1B), Conduent (Public Transit for $164M), and Sun Communities (UK assets for ~$1.03B). Distress is concentrated among micro-cap biotechs and struggling tech firms, with 4 companies executing reverse stock splits to maintain exchange listings and 2 receiving delisting notices. Period-over-period data, though limited, shows mixed results: Hims & Hers grew revenue 44.8% YoY but missed guidance, while Picard Medical grew revenue 85% YoY but saw net losses widen. Insider activity is sparse, but the prevalence of related-party transactions and distressed financings suggests management is prioritizing survival over shareholder value. The overall sentiment is cautious, with a clear trend toward deleveraging, portfolio simplification, and reliance on capital markets for liquidity.

50 high priority 50 total filings
· daily

US Executive Officer Management Changes SEC — May 21, 2026

The May 21, 2026 regulatory filings reveal a period of significant leadership upheaval across US equities, with 13 CEO/President departures or successions, 8 CFO changes, and 16 director shifts, concentrated in financials, technology, and healthcare. Period-over-period analysis from the enriched data shows a clear divergence: while several companies like Jet.AI and NRG Energy are aggressively pivoting toward AI infrastructure (with Jet.AI's cash position surging from $1.8M to $13.5M but revenue collapsing 51.6% YoY), traditional sectors face margin compression and shareholder dissent. Notably, 8 of 50 filings (16%) revealed advisory say-on-pay votes with >7% opposition, signaling growing governance concerns, and 5 companies saw director elections with >10% against votes. Insider activity was limited but material: the Radian Group CEO succession ($1M base + $14M total compensation package) and Sterling Infrastructure's CEO extension with a unique 'successor-onboarding' RSU vesting condition highlight a trend toward performance-based retention. Capital allocation signals are mixed—Aebi Schmidt and Valhi declared stable dividends, while Rithm Capital's 35M share reserve increase (69.24M total) amid 15% advisory vote opposition suggests potential dilution risk. The most critical development is Glimpse Group's near-total leadership vacuum (CEO, CFO, Chair all resigned), creating acute uncertainty, while Kohl's 5.2M share plan amendment passed despite 19.8M broker non-votes signals cautious but ongoing retail restructuring.

50 high priority 50 total filings
· daily

US Corporate Board Director Changes SEC Filings — May 21, 2026

The 50 filings from May 21, 2026, reveal a significant wave of leadership transitions across US public companies, with a notable concentration in the financial and energy sectors. A key theme is the high level of shareholder dissent on executive compensation and equity plan approvals, with several companies (BankUnited, MaxLinear, ANI Pharmaceuticals) seeing 7-15% opposition, signaling growing investor activism. The data shows a clear pattern of insider confidence, with several companies appointing new CFOs and CEOs, while others like Glimpse Group and Jet.AI face near-complete leadership turnover or severe financial distress. Capital allocation remains mixed, with dividend increases at Aebi Schmidt and American Tower contrasting with ongoing cash burn at Jet.AI and leadership departures at Omega Healthcare. The most critical development is the high materiality events at Glimpse Group (9/10) and Jet.AI (9/10), which present both significant risk and potential turnaround opportunities. Overall, the filings suggest a market in transition, with companies aggressively managing succession plans while facing heightened shareholder scrutiny on governance and pay practices.

50 high priority 50 total filings
· daily

US Merger & Acquisition SEC Filings — May 21, 2026

Today's digest covers 9 SEC filings, with 5 new entries and 4 for context, revealing a bifurcated M&A landscape. The most material developments are two transformative acquisitions: Nocopi Technologies' $2.65M purchase of Polymeric US, which more than triples its revenue base, and Ondas Holdings' acquisition of Omnisys, which adds over $100M in high-margin defense revenue. However, the SPAC market shows significant stress, with GSR V Acquisition Corp. reporting a going concern warning and an accumulated deficit of $7.3M despite a $230M IPO. Period-over-period comparisons are limited as most filings are for newly formed SPACs, but the operational companies (Nocopi, Ondas) show strong forward-looking revenue growth. Insider activity is notable at Nocopi, where a new director and an affiliate purchased shares in a private placement, signaling confidence. Capital allocation is mixed, with Nocopi using a mix of cash and stock (dilutive) while Ondas pursues a high-growth, high-margin acquisition. The overarching theme is a 'haves vs. have-nots' dynamic: companies with clear operational targets (Nocopi, Ondas) are executing, while cash-rich SPACs face existential risks.

9 high priority 9 total filings
· monthly

US Pre-Market SEC Filings Roundup — May 21, 2026

Overnight filings reveal a market bifurcated between aggressive corporate restructuring and operational headwinds. The most significant development is the transformative $1.03B UK asset sale by Sun Communities and the blockbuster AvalonBay-Equity Residential merger, signaling major consolidation in real estate. In earnings, Deere & Co. posted a 5% revenue increase but saw a 2% profit decline, with a sharp 39% drop in its core Production & Precision Agriculture segment, highlighting a mixed industrial outlook. Conversely, e.l.f. Beauty reported a strong 24.6% revenue surge, but net income collapsed 76.5% due to acquisition-related charges, a classic growth-at-a-cost story. A notable cluster of 14 Puerto Rico closed-end funds is pursuing a strategic shift to open-end structures, a potential liquidity catalyst for a previously illiquid market. Insider activity was sparse, but significant shareholder dissent was observed at Rocket Pharmaceuticals, where a director received only 68.2% support. Overall, the data points to a market where balance sheet strength and strategic clarity are rewarded, while companies facing operational decay (DHTI) or dilution risk (Snail, Inc.) are flashing clear warning signs.

27 high priority 23 medium 50 total filings
· daily

Federal Construction & Infrastructure Contracts — May 20, 2026

This digest covers a single $62.7 million civilian contract awarded by the Department of State to SICRA ILE DE FRANCE for construction of a residential facility in Paris. The contract is entirely civilian, with no defense exposure, and represents a niche opportunity in overseas diplomatic infrastructure. The highest-conviction signal is neutral, reflecting the absence of a publicly traded parent and limited direct portfolio impact. Key risks include execution pressure from the firm-fixed-price structure and potential budget volatility for State Department foreign operations. Investors should monitor follow-on awards and cost performance disclosures for sector-wide margin implications.

1 total filings
· daily

Defense Manufacturing Contracts — May 20, 2026

The single contract in this period, a $569.5M firm-fixed-price delivery order from NASA to Northrop Grumman for the JPSS-2 spacecraft, represents a purely civilian space systems award with no defense exposure. The aggregate obligation is entirely non-defense, highlighting NASA's continued investment in critical polar satellite infrastructure for weather and climate monitoring. The highest-conviction signal is bullish for Northrop Grumman, given the 13-year performance period and high strategic importance, but the fixed-price structure introduces execution risk on a complex space vehicle program. Key watch items include progress on JPSS-2 delivery milestones and the potential exercise of $37.2M in options to increase total contract value.

1 total filings
· daily

DHS Homeland Security Contracts — May 20, 2026

This digest covers a single $98.8M civilian contract from the Department of Homeland Security (DHS) to Leidos, Inc., representing 100% of the period's total obligation. The contract is for low-energy non-intrusive inspection systems for Customs and Border Protection (CBP), a firm-fixed-price delivery order with options extending to 2033. The highest-conviction signal is neutral: the award signals stable border security technology spending and Leidos' execution capability, but the long duration, 22% subaward concentration, and fixed-price risk temper the bullish case. Key risk is DHS budget appropriations for border technology, which could affect option exercise or renewal beyond 2027.

1 total filings